Skip to main content
SpringerLink
Log in

The progestin-only oral contraceptive —its place in postpartum contraception

  • Published:
Advances in Contraception

Abstract

The progestin-only oral contraceptive (POC) is not a widely-used method of contraception, possibly due to competition from other contemporary contraceptive methods or misunderstanding and prejudices among clients and/or service providers. Because of its underuse, the POC, as a contraceptive method, is under-studied.

This article evaluates the general merits of the POC and its disadvantages relative to combined oral contraceptives (COCs) and other contraceptive methods, specifically during the postpartum period and particularly for breastfeeding women. We find that the POC appears to be a safe and acceptable contraceptive method for postpartum women who are fully or nearly fully breastfeeding at six months postpartum or when menstruation returns. The POC could be considered for use at any time by non-breastfeeding postpartum women. The need for empirical studies of the POC is also discussed.

Resumé

La méthode de contraception par les produits ne contenant que de la progestine (POC) administrés par voie orale n'est pas largement utilisée, sans doute en raison de la concurrence que lui font d'autres méthodes modernes ou à cause de malentendus, voire de préjugés, de la part des clientes et/ou de ceux qui offrent ce service. Etant peu utilisé en tant que méthode contraceptive, le POC est aussi moins étudié.

L'article présenté évalue les mérites généraux de ces produits et leurs inconvénients en les comparant à des contraceptifs oraux combinés (COC) et à d'autres méthodes de contraception, et cela spécifiquement durant la période du post-partum et plus particulièrement chez les femmes qui allaitent. On a constaté que les POC semblent constituer une méthode de contraception sûre et acceptable après le post-partum chez les femmes qui allaitent entièrement, ou presque, six mois après l'accouchement ou lorsque la menstruation reprend. On pourrait envisager l'utilisation des POC à n'importe quel moment après l'accouchement chez les femmes qui n'allaitent pas. L'article examine également la nécessité de conduire des études empiriques sur les POC.

Resumen

El método anticonceptivo oral con productos que contienen sólo progesterona (POC) no se utiliza en gran medida, sin duda debido a la competencia de otros métodos modernos o a causa de malentendidos y prejuicios de parte de las clientas y/o de los proveedores de este servicio. Debido a su escaso uso, el POC ha sido poco estudiado.

Este artículo evalúa los méritos generales del POC y sus inconvenientes en comparación con los anticonceptivos orales combinados (COC) y otros métodos anticonceptivos, específicamente durante el período de posparto y, en particular, en las mujeres que amamantan. Se ha determinado que el POC parece constituir un método anticonceptivo seguro y aceptable en el posparto para las mujeres que amamantan exclusivamente, o casi exclusivamente, seis meses después del parto o cuando se reanuda la menstruación. Se podría considerar el uso del POC en cualquier momento después del parto entre las mujeres que no amamantan. Este artículo examina asimismo la necesidad de realizar estudios empíricos relativos at POC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. ThapaS., ShortR.V. and PottsM. (1988). Breast feeding, birth spacing and their effects on child survival.Nature,355, 679–682

    Google Scholar 

  2. KennedyK.I., RiveraR. and McNeillyA.S. (1989). Consensus statement on the use of breastfeeding as a family planning method.Contraception,39, 477–496

    PubMed  Google Scholar 

  3. HowieP.W. (1985). The progestogen-only pill.Br. J. Obstet. Gynaecol.,92, 1001–1002

    PubMed  Google Scholar 

  4. Population Reports (1975). Minipill — A limited alternative for certain women. Series A, Number 3

  5. FotherbyK. (1982). The progestogen-only pill.Br. J. Fam. Plann.,8, 7–10

    Google Scholar 

  6. VesseyM.P., LawlessM., YeatesD. and McPhersonK. (1985). Progestogen-only oral contraception. Findings in a large prospective study with special reference to effectiveness.Br. J. Fam. Plann.,10, 121–126

    Google Scholar 

  7. GrahamS. and FraserI. (1982). The progestogen-only mini-pill.Contraception,26, 373–388

    PubMed  Google Scholar 

  8. McCannM.S., LiskinL.S., PiotrowP.T. et al. (1981). Breast-feeding, fertility and family planning.Pop. Rep. Series J,IX, 525–575

    Google Scholar 

  9. World Health Organization Special Programme of Research, Development, and Research Training in Human Reproduction, Task Force on Oral Contraceptives (1984). Effects of hormonal contraceptives on milk and infant growth.Contraception,30, 505–522

    Google Scholar 

  10. Gupta, A.N., Mathur, V.S. and Gorg, S.K. (1977). Effect of oral contraceptives on the production and composition of human milk. In:Fertility Regulation during Human Lactation, Parkes, A.S., Thomson, A.M., Potts, M., Herbertson, M.A., eds.J. Biosoc. Sci. Suppl.,4, 123–133

  11. Population Reports (1988). Lower-dose pills. Series A, Number 7

  12. CantoT.E., VeraL.E., PolancoL.E. and ColvenC.E. (1989). Mini-pill in lactating women.Contraception,39, 589–601

    PubMed  Google Scholar 

  13. HowieP.W. and McNeillyA.S. (1983). Breast feeding and birth control. In:Progress in Obstetrics and Gynecology, StuddJ., ed. Churchill Livingstone, Edinburgh, pp. 136–150

    Google Scholar 

  14. McCannM.S., MoggiaA.V., HigginsJ.E. et al. (1989). The effects of a progestin-only oral contraceptive (levonorgestrel 0.03) on breast-feeding.Contraception,40, 635–648

    PubMed  Google Scholar 

  15. MoggiaA.V., HarrisG.S., DunsonT.R. et al. (1991). A comparative study of a progestin-only oral contraceptive versus non-hormonal methods in lactating women in Buenos Aires, Argentina.Contraception,44, 31–43

    PubMed  Google Scholar 

  16. BhatiaS., BeckerS. and KimY. (1982). The effect on fecundity of pill acceptance during postpartum amenorrhea in rural Bangladesh.Stud. Fam. Plann.,13, 200–207

    PubMed  Google Scholar 

  17. FraserI.S. (1991). A review of the use of progestogen-only minipills for contraception during lactation.Reprod. Fertil. Dev.,3, 245–254

    PubMed  Google Scholar 

  18. LabbokM.H. (1985). Contraception during lactation: considerations in advising the individual and in formulating programme guidelines.J. Biosoc. Sci.,9, 55–66

    Google Scholar 

  19. World Health Organization's Task Force on Oral Pill (1982). A randomized double-blind study of two combined and two progestogen-only contraceptives.Contraception,25, 243–252

    Google Scholar 

  20. PostlethwaiteD.L. (1979). Pregnancy rate of a progestogen-only contraceptive.Practitioner,222, 272–275

    PubMed  Google Scholar 

  21. BissetA.M., Dingwall-FordyceI. and HamiltonM.I.K. (1990). The efficacy of the progestogen-only pill as a contraceptive method.Br. J. Fam. Plann.,16, 84–87

    Google Scholar 

  22. BroomeM. and FotherbyK. (1990). Clinical experience with the progestogen-only pill.Contraception,42, 489–495

    PubMed  Google Scholar 

  23. DiazS., HerrerosC., JuezG. et al. (1985). Fertility regulation in nursing women: influence of Norplant levonorgestrel implants upon lactation and infant growth.Contraception,32, 53–74

    PubMed  Google Scholar 

  24. ShaabanM.M., SalemH.T. and AbdullahK.A. (1985). Influence of levonorgestrel contraceptive implants, Norplant, initiated early postpartum upon lactation and infant growth.Contraception,32, 623–635

    PubMed  Google Scholar 

  25. AffandiB., KarmadibrataS., PrihartonoJ., LubisF. and SamilR.S. (1986). Effect of Norplant on mothers and infants in the postpartum period.Adv. Contracept.,2, 371–380

    PubMed  Google Scholar 

  26. World Health Organization, Special Program of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation (1990). Microdose intravaginal levonorgestrel contraception: A multicenter clinical trial. I. Contraceptive efficacy and side effects.Contraception,41, 105–124

    Google Scholar 

  27. PaulsenM.L., VaradayA., BrownB.W. and KalmanS.M. (1974). A randomized contraceptive trial comparing a daily progestogen with a combined oral contraceptive steroid.Contraception,9, 497–506

    PubMed  Google Scholar 

  28. ElsteinM. (1970). Low-dose progestogens as contraceptive agents.IPPF Med. Bull.,4, 204

    Google Scholar 

  29. Hatcher, R.A., Guest, F., Stewart, G.K.et al. (1988).Contraceptive Technology, 1988–1989, Printed Matter Inc., pp. 117–118

  30. MillsA. (1987). The forgotten progestogen only pill.Br. J. Fam. Plann.,12, 44–46

    Google Scholar 

  31. FotherbyK. (1989). The progestogen-only pill. In:Contraception: Sciences and Practice, G.M.Filshie and J.Guillebaud, eds. Butterworth: London, pp. 94–108

    Google Scholar 

  32. TayobY., AdamsJ., JacobH. et al. (1985). Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only contraception.Br. J. Obstet. Gynaecol.,92, 1003–1009

    PubMed  Google Scholar 

  33. World Health Organization (1981). The effect of female sex hormones on fetal development and infant health.Technical Report Series,657, 29–52

    Google Scholar 

  34. NilssonS. and NygrenK. (1979). Transfer of contraceptive steroid to human milk.Res. Hum. Reprod.,II, 1–2

    Google Scholar 

  35. JohanssonE. and OldblindV. (1987). The passage of exogenous hormones into breast milk —possible effects.Int. J. Gynaecol. Obstet.,25, 111–114

    PubMed  Google Scholar 

  36. Consensus Statement (1988). Breastfeeding as a family planning method.Lancet,2, 1204–1205

    Google Scholar 

  37. GrayR.H., CampbellO.M., ApeloR. et al. (1990). Risk of ovulation during lactation.Lancet,335, 25–29

    PubMed  Google Scholar 

  38. ShortR.V., LewisP.R., RenfreeM.B. and ShawG. (1991). Contraceptive effects of extended lactational amenorrhoea: beyond the Bellagio Consensus.Lancet,337, 715–717

    PubMed  Google Scholar 

  39. DiazS., RodriguezG., PeraltaO. et al. (1988). Lactational amenorrhea and the recovery of ovulation and fertility in fully nursing Chilean women.Contraception,38, 53–67

    PubMed  Google Scholar 

  40. LabbokM., Koniz-BooherP., SheltonJ. and KrasovecK. (1990).Guidelines for Breastfeeding in Family Planning and Child Survival Programs. Georgetown University, Washington, D.C.

    Google Scholar 

  41. JellifeD.B. and JellifeE.F.P. (1985). Lactation amenorrhea: an important present-day component of family planning programmes. Editorial.J. Trop. Pediatr.,31, 240–241

    PubMed  Google Scholar 

  42. Family Planning Association (FPA) (1981).Method Instruction Sheet: The Progestogen-only Pill. FPA, London

    Google Scholar 

  43. WilsonE.S., CruickshankJ., McMasterM. et al. (1984). A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.Br. J. Obstet. Gynaecol.,91, 1254–1260

    PubMed  Google Scholar 

  44. IPPF (1990). New IPFF statement on breast feeding, fertility and postpartum contraception.IPPF Medical Bulletin,24(2), 2–4

    Google Scholar 

  45. LaukaranV.H. (1981). Contraceptive choices for lactating women: suggestions for postpartum family planning.Stud. Fam. Plann.,12, 156–163

    PubMed  Google Scholar 

  46. PotterL. and Williams-DeaneM. (1990). The importance of oral contraceptive compliance.IPPF Med. Bull.,24, 2–3

    Google Scholar 

  47. RosmanA.W. (1990). Safety and efficacy of progesterone-only oral contraception in lactating women: a multicenter international trial.Adv. Contracept.,6, 249

    Google Scholar 

  48. WestC.P. (1983). The acceptability of a progestogen-only contraceptive during breast-feeding.Contraception,27, 563–569

    PubMed  Google Scholar 

  49. FossG.L. and FotherbyK. (1975). Long-term use of daily administration of low doses of norgestrel as an oral contraceptive.J. Biosoc. Sci.,7, 269–272

    PubMed  Google Scholar 

  50. KennedyK.I. (1992). Fertility, sexuality and contraception during lactation. In:Breastfeeding and Human Milk, RiordanJ., AuerbachK., eds. Jones and Bartlett Publishers Inc., Munteray, CA (In press)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Family Health International, PO Box 13950, 27709, Research Triangle Park, NC, USA

    I. -C. Chi, M. Robbins & S. Balogh

Authors
  1. I. -C. Chi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Robbins
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Balogh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chi, I.C., Robbins, M. & Balogh, S. The progestin-only oral contraceptive —its place in postpartum contraception. Adv Contracept 8, 93–103 (1992). https://doi.org/10.1007/BF01849746

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01849746

Keywords

Search

Navigation